Literature DB >> 24920080

Ca2+ switches the effect of PS-containing membranes on Factor Xa from activating to inhibiting: implications for initiation of blood coagulation.

Tilen Koklic, Rinku Majumder1, Barry R Lentz1.   

Abstract

Calcium (Ca2+) plays a pivotal role in cellular and organismal physiology. The Ca2+ ion has an intermediate protein-binding affinity and thus it can serve as an on/off switch in the regulation of different biochemical processes. The serum level of ionized Ca2+ is regulated with normal ionized Ca2+ being in the range 1.10-1.3 mM. Hypocalcaemia (free Ca2+<1.1 mM) in critically ill patients is commonly accompanied by haemostatic abnormalities, ranging from isolated thrombocytopenia to complex defects such as disseminated intravascular coagulation, commonly thought to be due to insufficient functioning of anticoagulation pathways. A small amount of fXa (Factor Xa) produced by Factor VIIa and exposed tissue factor is key to initiating blood coagulation by producing enough thrombin to induce the later stages of coagulation. fXa must bind to PS (phosphatidylserine)-containing membranes to produce thrombin at a physiologically significant rate. In the present study, we show that overall fXa activity on PS-containing membranes is sharply regulated by a 'Ca2+ switch' centred at 1.16 mM, below which fXa is active and above which fXa forms inactive dimers on PS-exposing membranes. Our data lead to a mathematical model that predicts the variation of fXa activity as a function of both Ca2+ and membrane concentrations. Because the critical Ca2+ concentration is at the lower end of the normal plasma ionized Ca2+ concentration range, we propose a new regulatory mechanism by which local Ca2+ concentration switches fXa from an intrinsically active form to a form requiring its cofactor [fVa (Factor Va)] to achieve significant activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24920080      PMCID: PMC4254810          DOI: 10.1042/BJ20140130

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

Review 1.  Biochemistry and physiology of blood coagulation.

Authors:  K G Mann
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Soluble phosphatidylserine triggers assembly in solution of a prothrombin-activating complex in the absence of a membrane surface.

Authors:  Rinku Majumder; Gabriel Weinreb; Xin Zhai; Barry R Lentz
Journal:  J Biol Chem       Date:  2002-06-03       Impact factor: 5.157

3.  Cooperative roles of factor V(a) and phosphatidylserine-containing membranes as cofactors in prothrombin activation.

Authors:  Gabriel E Weinreb; Kasturi Mukhopadhyay; Rinku Majumder; Barry R Lentz
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

4.  Role of procoagulant lipids in human prothrombin activation. 2. Soluble phosphatidylserine upregulates and directs factor X(a) to appropriate peptide bonds in prothrombin.

Authors:  Mou Banerjee; Rinku Majumder; Gabriel Weinreb; Jianfang Wang; Barry R Lentz
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

5.  Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes.

Authors:  Jogin R Wu; Chaoming Zhou; Rinku Majumder; Daniel D Powers; Gabriel Weinreb; Barry R Lentz
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

6.  Localization of phosphatidylserine binding sites to structural domains of factor Xa.

Authors:  Arvind Srivastava; Jianfang Wang; Rinku Majumder; Alireza R Rezaie; Johan Stenflo; Charles T Esmon; Barry R Lentz
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

7.  Specificity of soluble phospholipid binding sites on human factor Xa.

Authors:  Mou Banerjee; Daryl C Drummond; Arvind Srivastava; David Daleke; Barry R Lentz
Journal:  Biochemistry       Date:  2002-06-18       Impact factor: 3.162

8.  Effects of water soluble phosphotidylserine on bovine factor Xa: functional and structural changes plus dimerization.

Authors:  Rinku Majumder; Jianfang Wang; Barry R Lentz
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

Review 9.  Microparticles in cardiovascular diseases.

Authors:  Marja J VanWijk; E VanBavel; A Sturk; R Nieuwland
Journal:  Cardiovasc Res       Date:  2003-08-01       Impact factor: 10.787

Review 10.  Coagulation abnormalities in critically ill patients.

Authors:  Marcel Levi; Steven M Opal
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  5 in total

1.  Endosulfan activates the extrinsic coagulation pathway by inducing endothelial cell injury in rats.

Authors:  Lianshuang Zhang; Jialiu Wei; Fangzi Guo; Junchao Duan; Yanbo Li; Zhixiong Shi; Yumei Yang; Xianqing Zhou; Zhiwei Sun
Journal:  Environ Sci Pollut Res Int       Date:  2015-06-02       Impact factor: 4.223

2.  Adiponectin alleviates blood hypercoagulability via inhibiting endothelial cell apoptosis induced by oxidative stress in septic rats.

Authors:  Yun Hou; Xi-Feng Wang; Zhi-Qiang Lang; Wei Zhao; Yinchuan Jin; Hong-Qin Zhang; Lian-Shuang Zhang
Journal:  Iran J Basic Med Sci       Date:  2018-10       Impact factor: 2.699

Review 3.  The Role of Serum Calcium Level in Intracerebral Hemorrhage Hematoma Expansion: Is There Any?

Authors:  Mostafa Jafari; Mario Di Napoli; Yvonne H Datta; Eric M Bershad; Afshin A Divani
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

4.  Phosphatidylserine and phosphatidylethanolamine regulate the structure and function of FVIIa and its interaction with soluble tissue factor.

Authors:  Tanusree Sengupta; Tilen Koklic; Barry R Lentz; Rinku Majumder
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

5.  Orchestrated cellular, biochemical, and biomechanical optimizations endow platelet-rich plasma-based engineered cartilage with structural and biomechanical recovery.

Authors:  Ketao Wang; Ji Li; Yuxing Wang; Yaqiang Wang; Yuanyuan Qin; Fei Yang; Mingzhu Zhang; Heng Zhu; Zhongli Li
Journal:  Bioact Mater       Date:  2021-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.